|

BCB-276 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • BrainChild Bio, Inc1

Indications

  • Adult Cancer Patients1
  • DMG1
  • DIPG1
  • CNS Tumor, Childhood1
  • CNS Tumor, Adult1

Los Angeles, California1 trial

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Children's Hospital Los Angeles

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.